verified SJR 0,272 · Q3

United States · Springer Science + Business...

workspace_premium Q3 — Oncology lock_open Open Access

Current Colorectal Cancer Reports

Current Colorectal Cancer Reports is a journal indexed in SJR in Oncology and Gastroenterology with an H index of 29. It has a price of 2590 €. It has an SJR impact factor of 0,272 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,272.

ISSN: 1556-3790

Publisher: Springer Science + Business Media

Category: Oncology

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,272 Q3

H-index 29

Acceptance rate pie_chart

36%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.590 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

0,272

H-index

Docs (year)

Docs 3y

Total refs

396

Cites 3y

Citable 3y

Cites/Doc 2y

0.85

Ref/Doc

49.5

Immediate OA

2590 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical Relevance of Apoptotic Regulatory Proteins in Colorectal Cancers

Why Cetuximab is Not Active in the Adjuvant Setting

Fecal Tests: From Blood to Molecular Markers

Factoring drug-free intervals into the management of patients with advanced colorectal cancer

Evolving end points for clinical trials in advanced colorectal cancer

DNA Methylation and Colorectal Cancer

Distinctive Tumor Biology of MSI-High Colorectal Cancer

Decreased-Purgation CT Colonography: State of the Art

Cyclooxygenase-2 Expression and Recurrence of Colorectal Adenomas: Effect of Aspirin Chemoprevention

Cutaneous adverse reactions to therapeutic monoclonal antibodies for cancer

Current Trends in the Management of Low Rectal Tumors: Transanal Total Mesorectal Excision

Current Status of Imaging to Evaluate Liver Metastases From Colorectal Cancer

SHOW MORE ARTICLES

Colorectal Cancer in the Elderly: How Do We Tailor Treatment with Chemotherapy and Radiotherapy Most Appropriately?

"The Role of Primary Tumor Resection (PTR) in Metastatic Colorectal Cancer"

Clinical Reasons for Initiation of Adjuvant Phase III Trials on Colon Cancer

Choosing between short-course preoperative radiotherapy and long-course chemoradiation therapy

Chemotherapy-associated liver injury: Does it really matter?

Chemotherapy intensification

Chemoprevention of Colorectal Cancer in High-Risk Patients: from Molecular Targets to Clinical Trials

Best Strategy in the Approach of Advanced Colorectal Cancer: Aggressive or Non-aggressive Chemotherapy?

Advances in immunotherapy for colorectal malignancies

Adjuvant therapy for colon cancer based on pharmacogenomics?

Adjuvant HIPEC in Colorectal Cancer

Adding cetuximab to a standard chemotherapy regimen containing bevacizumab in first-line therapy for colorectal cancer decreases efficacy: Results from the CAIRO2 trial

FAQs

Current Colorectal Cancer Reports has an SJR of 0,272 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is 2590 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Current Colorectal Cancer Reports is 36%.

Current Colorectal Cancer Reports

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Colorectal Cancer Reports?

What is the APC / publication cost?

What is the acceptance rate?